India bumps certifications to national level

Prompted by WHO concerns, Indian drug makers will begin approaching national regulatory authorities rather than state administrators to get facilities and export products certified. The switch, effective next month, is an attempt to streamline the regulatory process for pharmaceutical exports, but some expect it to add delays. Article

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.